Atossa Therapeutics, Inc. Common Stock (NASDAQ: ATOS) last traded at $2.45, down 4.30% on the session. The quote above updates while this page is open; the figures below are drawn from Atossa Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Atossa Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ATOS. Its market capitalisation is $24.45 million.
Valuation measures for Atossa Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $24.45M |
|---|---|
| Enterprise value | $3.81M |
| Price / book | 0.91 |
| Beta | 1.02 |
Trailing-twelve-month figures tagged in Atossa Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$37.71M |
| EPS (TTM) | -$4.34 |
|---|
| Return on equity | -140.55% |
|---|
| Cash | $26.09M |
|---|
Range and volume for ATOS over the past 52 weeks.
| 52-week high | $16.50 |
|---|---|
| 52-week low | $1.70 |
| Volume | 8.8K |
| Average volume | 64.3K |
| Previous close | $2.56 |
Invest a chosen dollar amount in Atossa Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ATOS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.